InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: ohm20 post# 47608

Wednesday, 10/23/2019 4:23:00 AM

Wednesday, October 23, 2019 4:23:00 AM

Post# of 232695
I agree that the Combo dosage boost requirement was questionable by FDA.

It should have been either or .. either allow some sort of mono therapy with high dosabe already or stick to the plan.
We just don't know all details, but it was at least a vote of monotherapy confidence. The double edged sword, yes.

Maybe the FDA should allow at a certain safety stage (no harm) to have patients chose their drug ... but that is another debate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News